Advertisement

Picture Berlin Partner Top News CareSyntax Raises $180m Funding 650x100px
Document › Details

Cellink AB. (3/11/21). "Press Release: Cellink AB Announces an Offering of Senior Unsecured Convertible Bonds Convertible into Class B Shares and a Class B Share Issue in an Expected Amount of SEK 2.75 Billion [NOT FOR US, CA, et al.]". Gothenburg.

Organisations Organisation Cellink AB (Nasdaq First North: CLNK)
  Today Bico Group AB (publ)
  Group Bico (Group)
  Organisation 2 MatTek Corporation
  Group Bico (Group)
Products Product BIOTECH
  Product 2 investment banking
Index terms Index term Cellink–SEVERAL: investment, 202103 capital increase SEK1.5b directed issue of new Class B Shares at SEK420/share
  Index term 2 Cellink–SEVERAL: credit, 202103–202603 convertible bonds SEK1.5b at 2.875%pa convertible into B Class shares at SEK598.5/share
Persons Person Gatenholm, Erik (Cellink 201908 CEO + Co-Founder RESIGNED as CEO of Bico 11/23 LEFT Board 5/24)
  Person 2 Danielsson, Gusten (Cellink 201908–202204 CFO + Co-Founder LEFT 4/22)
     


   
Record changed: 2023-06-05

Advertisement

Picture Berlin Partner Join Cluster HealthCapital Berlin Brandenburg 650x200px

More documents for Bico (Group)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Advertisement

Picture EBD Group BIO-Europe 2024 Stockholm BEU24 650x300px




» top